Direxion Daily S&P Biotech Bull 3x Shares Rating $245.60 -8.17 (-3.22%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.67Holdings in LABU have an aggregate rating of Moderate Buy based on 220 analyst ratings issued in the past year covering 14 companies (7.9% of the portfolio).LABU Aggregate Price Target$245.60High Prediction$245.60Average Prediction$245.60Low Prediction$245.60Holdings in LABU have an aggregate price target of $245.60 and a range of $245.60 to $245.60 covering 14 companies (7.9% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 LABU Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.65%APGEApogee Therapeutics$134.28+0.0%1.93 of 5 stars2.24$121.25 -9.7%21Positive News0.65%MRNAModerna$54.07-5.2%1.5748 of 5 stars1.82$40.00 -26.0%17Upcoming EarningsAnalyst ForecastGap Down0.59%KYMRKymera Therapeutics$110.57+0.2%1.8552 of 5 stars2.86$122.64 10.9%22Positive NewsGap Up0.58%VKTXViking Therapeutics$34.79-1.7%3.3664 of 5 stars2.67$97.00 178.8%12Upcoming Earnings0.57%ERASErasca$19.11-1.2%1.9627 of 5 stars2.64$21.64 13.2%11Trending News0.56%PRAXPraxis Precision Medicines$325.30+0.9%4.0794 of 5 stars2.95$563.50 73.2%22Positive News0.55%MIRMMirum Pharmaceuticals$113.03-1.2%2.8946 of 5 stars2.93$143.40 26.9%15Upcoming Earnings0.54%RYTMRhythm Pharmaceuticals$102.10-0.5%2.9798 of 5 stars2.76$138.29 35.4%17Positive News0.53%TWSTTwist Bioscience$90.27-2.3%1.5508 of 5 stars2.70$90.30 0.0%10Positive News0.53%PTGXProtagonist Therapeutics$136.11+0.5%1.5304 of 5 stars2.94$123.00 -9.6%17News CoveragePositive NewsAnalyst Upgrade0.53%RVMDRevolution Medicines$189.23+0.3%1.8255 of 5 stars2.95$144.67 -23.5%22News CoveragePositive NewsAnalyst Forecast0.53%ORKAOruka Therapeutics$92.16+0.2%3.628 of 5 stars2.82$134.30 45.7%11News CoveragePositive News0.52%PCVXVaxcyte$54.66-1.8%2.8886 of 5 stars2.44$86.00 57.3%9Positive News0.52%DNTHDianthus Therapeutics$103.87-0.9%2.2903 of 5 stars2.93$117.82 13.4%14News CoveragePositive News This page (NYSEARCA:LABU) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts